Table 3 Pharmacokinetic parameters of ganciclovir in new Zealand white rabbits following oral administration of valganciclovir hydrochloride (5 mg/kg).
Pharmacokinetic Parameter | Value | CV (%) |
|---|---|---|
Absorption | ||
Cmax (µg/mL) | 4.25 ± 0.77 | 18.1 |
Tmax (h)ᵃ | 2.0 (1.5–2.5) | 19.9 |
Distribution | ||
Vz/F (L) | 0.99 ± 0.13 | 12.9 |
Elimination | ||
t½ (h) | 2.94 ± 0.32 | 11.0 |
CL/F (L/h) | 0.24 ± 0.03 | 13.2 |
Exposure | ||
AUC0→ t (µg·h/mL) | 21.1 ± 2.6 | 12.3 |
AUC0→ ∞ (µg·h/mL) | 21.6 ± 2.7 | 12.6 |
MRT (h) | 4.52 ± 0.71 | 15.6 |